SYRE
#989
Spyre Therapeutics, Inc. - Common Stock
102.0 7 USD
+0.03%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
+3.15%
Variación mensual
+21.61%
Variación en los últimos 6 meses
+213.68%
Cambio anual
+326.89%
Cierres anteriores
98.9 5
Open
102.0 7
Mínimo
102.0 7
High
102.0 7
Volumen
177
Financials
- Market Capitalization 8.86 B
- Employee 112
- Founded 2013
- CEO N/A
- Website www.spyre.com
- Headquarter Delaware, United States
- FIGI BBG0067L94B2
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-23.79
Relación precio/flujo de caja
—
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 975 |  HALO Halozyme Therapeutics, Inc. - Common Stock | 75.82 USD | +1.03% | -5.74% | +8.87% | +13.50% | 8.99 B USD | ||
| 987 |  PRAX Praxis Precision Medicines, Inc. - Common Stock | 318.42 USD | -2.83% | -4.11% | +22.90% | +477.89% | 8.88 B USD | ||
| 990 |  CRNX Crinetics Pharmaceuticals, Inc. - Common Stock | 83.90 USD | +0.23% | +0.47% | +139.71% | +104.14% | 8.85 B USD | ||
| 997 |  PTGX Protagonist Therapeutics, Inc. - Common Stock | 135.46 USD | +3.19% | -2.73% | +22.21% | +80.30% | 8.71 B USD |